These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36094793)

  • 21. Cardiomyopathy correlates to nerve damage in p.A117S late-onset transthyretin amyloid polyneuropathy.
    Lin YH; Hsueh HW; Su MY; Cheng MF; Chiang MC; Juang JJ; Kao YH; Chang KC; Feng FP; Hsieh ST; Chao CC
    Ann Clin Transl Neurol; 2022 Sep; 9(9):1359-1369. PubMed ID: 35945697
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The neuropathy in hereditary transthyretin amyloidosis: A narrative review.
    Tozza S; Severi D; Spina E; Iovino A; Aruta F; Ruggiero L; Dubbioso R; Iodice R; Nolano M; Manganelli F
    J Peripher Nerv Syst; 2021 Jun; 26(2):155-159. PubMed ID: 33960565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel approaches to diagnosis and management of hereditary transthyretin amyloidosis.
    Carroll A; Dyck PJ; de Carvalho M; Kennerson M; Reilly MM; Kiernan MC; Vucic S
    J Neurol Neurosurg Psychiatry; 2022 Jun; 93(6):668-678. PubMed ID: 35256455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The diagnostic criteria for small fibre neuropathy: from symptoms to neuropathology.
    Devigili G; Tugnoli V; Penza P; Camozzi F; Lombardi R; Melli G; Broglio L; Granieri E; Lauria G
    Brain; 2008 Jul; 131(Pt 7):1912-25. PubMed ID: 18524793
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of autonomic innervation of the foot in familial amyloid polyneuropathy.
    Zouari HG; Ng Wing Tin S; Wahab A; Damy T; Lefaucheur JP
    Eur J Neurol; 2019 Jan; 26(1):94-e10. PubMed ID: 30102818
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuropathic pain experience in symptomatic and presymptomatic subjects carrying a transthyretin gene mutation.
    Tozza S; Luigetti M; Antonini G; Mazzeo A; Severi D; Di Paolantonio A; Leonardi L; Russo M; Romano A; Forcina F; Gentile L; Nolano M; Mattia C; Manganelli F
    Front Neurol; 2023; 14():1109782. PubMed ID: 36846120
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Small-fibre involvement in diabetic patients with neuropathic foot pain.
    Vlckova-Moravcova E; Bednarik J; Belobradkova J; Sommer C
    Diabet Med; 2008 Jun; 25(6):692-9. PubMed ID: 18544107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Late-onset hereditary ATTR V30M amyloidosis with polyneuropathy: Characterization of Brazilian subjects from the THAOS registry.
    Pinto MV; Pinto LF; Dias M; Rosa RS; Mundayat R; Pedrosa RC; Waddington-Cruz M
    J Neurol Sci; 2019 Aug; 403():1-6. PubMed ID: 31163298
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of inotersen on Neuropathy Impairment Score in patients with hereditary transthyretin amyloidosis with polyneuropathy.
    Yarlas A; Lovley A; Brown D; Vera-Llonch M; Khella S; Karam C
    BMC Neurol; 2023 Mar; 23(1):108. PubMed ID: 36932361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The diagnostic accuracy of Sudoscan in transthyretin familial amyloid polyneuropathy.
    Castro J; Miranda B; Castro I; de Carvalho M; Conceição I
    Clin Neurophysiol; 2016 May; 127(5):2222-7. PubMed ID: 27072093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recessive dystrophic epidermolysis bullosa results in painful small fibre neuropathy.
    von Bischhoffshausen S; Ivulic D; Alvarez P; Schuffeneger VC; Idiaquez J; Fuentes C; Morande P; Fuentes I; Palisson F; Bennett DLH; Calvo M
    Brain; 2017 May; 140(5):1238-1251. PubMed ID: 28369282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of autonomic outcomes in APOLLO, a phase III trial of the RNAi therapeutic patisiran in patients with hereditary transthyretin-mediated amyloidosis.
    González-Duarte A; Berk JL; Quan D; Mauermann ML; Schmidt HH; Polydefkis M; Waddington-Cruz M; Ueda M; Conceição IM; Kristen AV; Coelho T; Cauquil CA; Tard C; Merkel M; Aldinc E; Chen J; Sweetser MT; Wang JJ; Adams D
    J Neurol; 2020 Mar; 267(3):703-712. PubMed ID: 31728713
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Canadian Guidelines for Hereditary Transthyretin Amyloidosis Polyneuropathy Management.
    Alcantara M; Mezei MM; Baker SK; Breiner A; Dhawan P; Fiander A; Fine NM; Hahn C; Katzberg HD; Khayambashi S; Massie R; Matte G; Putko B; Siddiqi Z; Delgado D; Bril V
    Can J Neurol Sci; 2022 Jan; 49(1):7-18. PubMed ID: 33631091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of measures of polyneuropathy impairment in hATTR amyloidosis: From NIS to mNIS + 7.
    Dyck PJB; González-Duarte A; Obici L; Polydefkis M; Wiesman JF; Antonino I; Litchy WJ; Dyck PJ
    J Neurol Sci; 2019 Oct; 405():116424. PubMed ID: 31445300
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative sensory testing: a good tool to identify subclinical neuropathy in ATTRV30M amyloidosis patients?
    Conceição I; de Castro I; Diaz A; Castro J
    Amyloid; 2023 Jun; 30(2):239-243. PubMed ID: 36519495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chance or challenge, spoilt for choice? New recommendations on diagnostic and therapeutic considerations in hereditary transthyretin amyloidosis with polyneuropathy: the German/Austrian position and review of the literature.
    Dohrn MF; Auer-Grumbach M; Baron R; Birklein F; Escolano-Lozano F; Geber C; Grether N; Hagenacker T; Hund E; Sachau J; Schilling M; Schmidt J; Schulte-Mattler W; Sommer C; Weiler M; Wunderlich G; Hahn K
    J Neurol; 2021 Oct; 268(10):3610-3625. PubMed ID: 32500375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-resolution ultrasound of peripheral nerves in late-onset hereditary transthyretin amyloidosis with polyneuropathy: similarities and differences with CIDP.
    Leonardi L; Di Pietro G; Di Pasquale A; Vanoli F; Fionda L; Garibaldi M; Galosi E; Alfieri G; Lauletta A; Morino S; Salvetti M; Truini A; Antonini G
    Neurol Sci; 2022 May; 43(5):3387-3394. PubMed ID: 34802089
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced intraepidermal nerve fibre density in patients with hereditary transthyretin amyloidosis.
    Masuda T; Ueda M; Misumi Y; Nomura T; Inoue Y; Isoguchi A; Kanenawa K; Tasaki M; Yamashita T; Sonoda Y; Obayashi K; Ando Y
    Amyloid; 2019; 26(sup1):79-80. PubMed ID: 31343297
    [No Abstract]   [Full Text] [Related]  

  • 39. 6MWT performance correlates with peripheral neuropathy but not with cardiac involvement in patients with hereditary transthyretin amyloidosis (hATTR).
    Vita GL; Stancanelli C; Gentile L; Barcellona C; Russo M; Di Bella G; Vita G; Mazzeo A
    Neuromuscul Disord; 2019 Mar; 29(3):213-220. PubMed ID: 30718023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sudoscan in the evaluation and follow-up of patients and carriers with TTR mutations: experience from an Italian Centre.
    Luigetti M; Bisogni G; Romano A; Di Paolantonio A; Barbato F; Primicerio G; Rossini PM; Servidei S; Sabatelli M
    Amyloid; 2018 Dec; 25(4):242-246. PubMed ID: 30638075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.